Ligaba Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Special Precautions Use In Pregnancy & Lactation Adverse Reactions Side Effects Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Pregabalin

Indications/Uses

Neuropathic pain associated w/ diabetic peripheral neuropathy. Postherpetic neuralgia & fibromyalgia. Adjunctive therapy for adult patients w/ partial onset seizures.

Click to view Ligaba detailed prescribing information

Dosage/Direction for Use

Max: 150-600 mg/day. Neuropathic pain associated w/ diabetic peripheral neuropathy CrCl at least 60 mL/min Initially 50 mg tid. May be increased to 300 mg/day w/in 1 wk. Max: 100 mg tid. Postherpetic neuralgia CrCl at least 60 mL/min 75-150 mg bid or 50-100 mg tid. Initially 75 mg bid or 50 mg tid, may be increased to 300 mg/day w/in 1 wk. Patient who does not experience sufficient pain relief following 2-4 wk w/ 300 mg/day 300 mg bid or 200 mg tid. Adjunctive therapy for adult patient w/ partial onset seizure 150-600 mg/day in 2 or 3 divided doses. Management of fibromyalgia 300-450 mg/day. Initially 75 mg bid, may be increased to 150 mg bid w/in 1 wk & may further increase to 225 mg bid. Doses >450 mg/day is not recommended. Neuropathic pain associated w/ spinal cord injury 150-600 mg/day. Initially 75 mg bid, may be increased to 150 mg bid w/in 1 wk. Patient who does not experience sufficient pain relief after 2-3 wk w/ 150 mg bid 300 mg bid. Renal impairment CrCl ≥60 mL/min 150, 300, 450 or 600 mg/day bid or tid, 30-60 mL/min 75, 150, 225 or 300 mg/day bid or tid, 15-30 mL/min 25-50, 75, 100-150 or 150 mg as single daily dose or bid, <15 mL/min 25, 25-50, 50-75 or 75 mg as single daily dose.

Click to view Ligaba detailed prescribing information

Overdosage

View Ligaba overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food.

Special Precautions

Discontinue immediately if swelling of the face, mouth (tongue, lips & gums) & neck (throat & larynx); if myopathy is diagnosed or suspected or if markedly elevated creatinine kinase levels occurs. Diabetic patients. W/drawal of concomitant antiepileptic drugs. Suicidal ideation & behavior; peripheral edema; encephalopathy. Wt gain; blurred vision; decreased platelet count; PR interval prolongation, renal failure may occur. Patients w/ CHF NYHA class III or IV; history or potential of substance abuse. Concomitant use w/ drugs potential to produce constipation eg, opioid analgesics. Galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. May cause dizziness & somnolence & impair ability to drive or operate machinery. Pregnancy & lactation. Childn.

Click to view Ligaba detailed prescribing information

Use In Pregnancy & Lactation

Click to view Ligaba detailed prescribing information

Adverse Reactions

Dizziness, trouble concentrating, blurry vision, swelling of hands & feet, wt gain, dry mouth, sleepiness.

Click to view Ligaba detailed prescribing information

Storage

View Ligaba storage conditions for details to ensure optimal shelf-life.

Description

View Ligaba description for details of the chemical structure and excipients (inactive components).

Action

View Ligaba mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Anticonvulsants / Drugs for Neuropathic Pain

ATC Classification

N02BF02 - pregabalin ; Belongs to the class of gabapentinoids. Used to relieve pain and other conditions.

Regulatory Classification

Presentation/Packing

Form

Ligaba cap 75 mg

Packing/Price

30's

Ligaba

pregabalin

Manufacturer:

Mega Lifesciences

Distributor:

Metro Drug